Calls to allow patients to contribute to the cost of NHS services, including expensive cancer treatments have been renewed.'Co-payment', where …
GlaxoSmithKline is to buy up biopharmaceutical company Sirtris, which specialises in research into the ageing process and related diseases. The …
Acambis awarded smallpox vaccine contract by US governmentAcambis has received a $425 million, ten-year contract from the US Government agency, …
Falling sales of its blockbuster flu treatment Tamiflu have dented Roche's balance sheet. The Swiss company managed sales of 10.9 …
Roche's Actemra has been given its first green light, gaining marketing approval in Japan for the treatment of rheumatoid arthritis.Actemra …
The national meningitis vaccination programme successfully prevented any deaths in young people in England last year, according to a new …
Pfizer's blockbuster statin Lipitor has shown no impact on the treatment of Alzheimer's disease, scotching the company's hopes for a …
The Conservatives have attacked government efforts to reform the health service, warning that plans for new polyclinics will endanger the …
The 'value proposition' is a good example. It is a buzz-word used by marketers the world over, and yet far …
United Drug has broadened its reach with two new acquisitions, one in meetings and events and another in the field …
Novartis eyes Alcon to drive diversification strategy Novartis has agreed to acquire a controlling stake in ophthalmology specialist Alcon for …
A leading thinktank has criticised what it calls a lack of clarity in the debate over accountability in the NHS. …
AstraZeneca has settled its legal battle with Indian generics company Ranbaxy Laboratories over the US patents on Nexium, AstraZeneca's biggest …
One of the UK's leading pharmaceutical companies is to shift its tax base to the Republic of Ireland to benefit …
Roche is set to pay $160 million (£315 million) to buy UK biotech company Piramed, a move which will further …
The latest edition of the CMR International R&D Factbook shows that the mean time from protocol approval to final report …
Strong growth in respiratory product Spiriva once again led the way for Boehringer Ingelheim, which has just published results for …
Less than half of NHS staff believes patient care is a top priority for trusts, according to a survey from …